Inventor
TAYLOR VANESSA
US89 patents
⚠️ This page may combine multiple inventors who share the name “TAYLOR VANESSA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
RIGEL PHARMACEUTICALS INC
42 patentsUS7858633B2Dec 28, 2010
Cycloalkyl substituted pyrimidinediamine compounds and their uses
RIGEL PHARMACEUTICALS INC66 citations98
US7947698B2May 24, 2011
Compositions and methods for inhibition of the JAK pathway
RIGEL PHARMACEUTICALS INC55 citations97
US7834024B2Nov 16, 2010
Compositions and methods for inhibition of the JAK pathway
RIGEL PHARMACEUTICALS INC59 citations97
US7754714B2Jul 13, 2010
Cycloalkyl substituted pyrimidinediamine compounds and their uses
RIGEL PHARMACEUTICALS INC39 citations95
US10815206B2Oct 27, 2020
RIP1 inhibitory compounds and methods for making and using the same
RIGEL PHARMACEUTICALS INC16 citations94
US8735400B2May 27, 2014
Compositions and methods for inhibition of the JAK pathway
RIGEL PHARMACEUTICALS INC21 citations93
US7915273B2Mar 29, 2011
Compositions and methods for inhibition of the JAK pathway
RIGEL PHARMACEUTICALS INC33 citations93
US9982000B2May 29, 2018
Pyrazole compounds and method for making and using the compounds
RIGEL PHARMACEUTICALS INC16 citations92
US9067925B2Jun 30, 2015
Compositions and methods for inhibition of the JAK pathway
RIGEL PHARMACEUTICALS INC11 citations92
US7868013B2Jan 11, 2011
Cycloalkyl substituted pyrimidinediamine compounds and their uses
RIGEL PHARMACEUTICALS INC25 citations91
US10975064B2Apr 13, 2021
RIP1 inhibitory compounds and methods for making and using the same
RIGEL PHARMACEUTICALS INC14 citations86
US11479543B2Oct 25, 2022
Heterocyclic RIP1 kinase inhibitors
RIGEL PHARMACEUTICALS INC5 citations84
US11407736B2Aug 9, 2022
RIP1 inhibitory compounds and methods for making and using the same
RIGEL PHARMACEUTICALS INC4 citations84
US11332451B2May 17, 2022
RIP1 inhibitory compounds and methods for making and using the same
RIGEL PHARMACEUTICALS INC3 citations84
US10590121B2Mar 17, 2020
Kinase inhibitors and methods for making and using
RIGEL PHARMACEUTICALS INC10 citations84
US10421752B2Sep 24, 2019
Compositions and methods for inhibition of the JAK pathway
RIGEL PHARMACEUTICALS INC3 citations84
US10208075B2Feb 19, 2019
Pyrazole compounds and method for making and using the compounds
RIGEL PHARMACEUTICALS INC4 citations84
US10208074B2Feb 19, 2019
Pyrazole compounds and method for making and using the compounds
RIGEL PHARMACEUTICALS INC5 citations84
US10065946B2Sep 4, 2018
Benzazole compounds and methods for making and using the compounds
RIGEL PHARMACEUTICALS INC4 citations84
US9732073B2Aug 15, 2017
Compositions and methods for inhibition of the JAK pathway
RIGEL PHARMACEUTICALS INC4 citations84
US9725419B2Aug 8, 2017
Cycloalkyl substituted pyrimidinediamine compounds and their uses
RIGEL PHARMACEUTICALS INC7 citations84
US9611260B2Apr 4, 2017
Compositions and methods for inhibition of the JAK pathway
RIGEL PHARMACEUTICALS INC4 citations84
US9566283B2Feb 14, 2017
Compositions and methods for inhibition of the JAK pathway
RIGEL PHARMACEUTICALS INC3 citations84
US9248190B2Feb 2, 2016
Compositions and methods for inhibition of the JAK pathway
RIGEL PHARMACEUTICALS INC4 citations84
US9248132B2Feb 2, 2016
Compositions and methods for inhibition of the JAK pathway
RIGEL PHARMACEUTICALS INC4 citations84
US9084795B2Jul 21, 2015
Compositions and methods for inhibition of the JAK pathway
RIGEL PHARMACEUTICALS INC4 citations84
US8815848B2Aug 26, 2014
Compositions and methods for inhibition of the JAK pathway
RIGEL PHARMACEUTICALS INC8 citations84
US8343954B2Jan 1, 2013
Compositions and methods for inhibition of the JAK pathway
RIGEL PHARMACEUTICALS INC8 citations84
US8053434B2Nov 8, 2011
Kinase inhibitors and their uses
RIGEL PHARMACEUTICALS INC5 citations74
US11584758B2Feb 21, 2023
RIP1K inhibitors
RIGEL PHARMACEUTICALS INC5 citations73
US11530194B2Dec 20, 2022
Amide compounds and method for making and using
RIGEL PHARMACEUTICALS INC1 citations73
US11492349B2Nov 8, 2022
IRAK inhibitors and method for making and using
RIGEL PHARMACEUTICALS INC1 citations73
US11377428B2Jul 5, 2022
RIP1 inhibitory compounds and methods for making and using the same
RIGEL PHARMACEUTICALS INC2 citations73
US11370764B2Jun 28, 2022
RIP1 inhibitory compounds and methods for making and using the same
RIGEL PHARMACEUTICALS INC2 citations73
US11370765B2Jun 28, 2022
RIP1 inhibitory compounds and methods for making and using the same
RIGEL PHARMACEUTICALS INC2 citations73
US11299486B2Apr 12, 2022
Benzazole compounds and methods for making and using the compounds
RIGEL PHARMACEUTICALS INC1 citations73
US11220496B2Jan 11, 2022
Compounds and method for treating autoimmune diseases
RIGEL PHARMACEUTICALS INC1 citations73
US11198689B2Dec 14, 2021
Compositions and methods for inhibition of the JAK pathway
RIGEL PHARMACEUTICALS INC2 citations73
US10947216B2Mar 16, 2021
Amide compounds and method for making and using
RIGEL PHARMACEUTICALS INC1 citations73
US10941140B2Mar 9, 2021
IRAK inhibitors and method for making and using
RIGEL PHARMACEUTICALS INC2 citations73
US10774076B2Sep 15, 2020
Benzazole compounds and methods for making and using the compounds
RIGEL PHARMACEUTICALS INC3 citations73
US10479783B2Nov 19, 2019
Compositions and methods for inhibition of the JAK pathway
RIGEL PHARMACEUTICALS INC2 citations73
LI HUI
5 patentsUS8415365B2Apr 9, 2013
Compositions and methods for inhibition of the JAK pathway
LI HUI31 citations96
US8399472B2Mar 19, 2013
Compositions and methods for inhibition of the JAK pathway
LI HUI26 citations96
US8324200B2Dec 4, 2012
Compositions and methods for inhibition of the JAK pathway
LI HUI23 citations96
US8410093B2Apr 2, 2013
Cycloalkyl substituted pyrimidinediamine compounds and their uses
LI HUI9 citations84
US8299087B2Oct 30, 2012
Compositions and methods for inhibition of the JAK pathway
LI HUI11 citations84
ATUEGBU ANDY
1 patentBHAMIDIPATI SOMASEKHAR
1 patentCHEN YAN
1 patentShowing the top 50 of 89 patents by PatentIndex Score.